Sterling Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.96M | Buy |
25,030
+22,535
| +903% | +$1.82M | 0.03% | 368 |
|
|
2026
Q1 | $216K | Buy |
2,495
+21
| +0.8% | +$2.01K | ﹤0.01% | 1144 |
|
|
2025
Q4 | $238K | Sell |
2,474
-36,226
| -94% | -$3.52M | ﹤0.01% | 1261 |
|
|
2025
Q3 | $3.69M | Buy |
38,700
+34,389
| +798% | +$3.16M | 0.05% | 236 |
|
|
2025
Q2 | $376K | Sell |
4,311
-22,568
| -84% | -$1.91M | 0.01% | 1058 |
|
|
2025
Q1 | $2.42M | Buy |
26,879
+497
| +2% | +$44.5K | 0.04% | 309 |
|
|
2024
Q4 | $2.11M | Sell |
26,382
-1,857
| -7% | -$161K | 0.03% | 391 |
|
|
2024
Q3 | $2.54M | Buy |
+28,239
| New | +$2.38M | 0.03% | 327 |
|
|
2019
Q3 | $114M | Sell |
1,046,185
-8,721
| -0.8% | -$910K | 1.08% | 14 |
|
|
2019
Q2 | $103M | Buy |
1,054,906
+20,200
| +2% | +$1.84M | 0.99% | 18 |
|
|
2019
Q1 | $94.2M | Buy |
1,034,706
+65,632
| +7% | +$5.87M | 0.93% | 19 |
|
|
2018
Q4 | $88.1M | Buy |
969,074
+2,075
| +0.2% | +$194K | 0.96% | 18 |
|
|
2018
Q3 | $95.1M | Sell |
966,999
-5,263
| -0.5% | -$487K | 0.86% | 28 |
|
|
2018
Q2 | $83.2M | Sell |
972,262
-3,172
| -0.3% | -$265K | 0.78% | 42 |
|
|
2018
Q1 | $78.2M | Buy |
975,434
+86,901
| +10% | +$7.17M | 0.74% | 45 |
|
|
2017
Q4 | $71.7M | Buy |
888,533
+796,118
| +861% | +$63.8M | 0.65% | 54 |
|
|
2017
Q3 | $7.19M | Buy |
92,415
+5,887
| +7% | +$489K | 0.07% | 212 |
|
|
2017
Q2 | $7.68M | Sell |
86,528
-7,934
| -8% | -$669K | 0.07% | 204 |
|
|
2017
Q1 | $7.61M | Sell |
94,462
-2,809
| -3% | -$219K | 0.07% | 207 |
|
|
2016
Q4 | $6.93M | Buy |
97,271
+28,080
| +41% | +$2.21M | 0.06% | 212 |
|
|
2016
Q3 | $5.98M | Sell |
69,191
-3,724
| -5% | -$325K | 0.06% | 219 |
|
|
2016
Q2 | $6.33M | Sell |
72,915
-2,478
| -3% | -$200K | 0.06% | 221 |
|
|
2016
Q1 | $5.65M | Buy |
75,393
+1,964
| +3% | +$148K | 0.05% | 234 |
|
|
2015
Q4 | $5.65M | Buy |
73,429
+2,852
| +4% | +$215K | 0.05% | 237 |
|
|
2015
Q3 | $4.72M | Sell |
70,577
-6,114
| -8% | -$450K | 0.04% | 249 |
|
|
2015
Q2 | $5.68M | Sell |
76,691
-11,800
| -13% | -$902K | 0.05% | 182 |
|
|
2015
Q1 | $6.9M | Buy |
+88,491
| New | +$6.71M | 0.06% | 154 |
|
|
2014
Q4 | – | Sell |
-62,710
| Closed | -$3.88M | – | 939 |
|
|
2014
Q3 | $3.88M | Buy |
62,710
+19,098
| +44% | +$1.21M | 0.05% | 216 |
|
|
2014
Q2 | $2.78M | Buy |
43,612
+19,894
| +84% | +$1.21M | 0.02% | 256 |
|
|
2014
Q1 | $1.46M | Buy |
23,718
+19,828
| +510% | +$1.15M | 0.01% | 461 |
|
|
2013
Q4 | $223K | Buy |
+3,890
| New | +$221K | ﹤0.01% | 762 |
|
Other funds holding MDT
Sterling Capital Management's MDT Position: Q2 2026 in Review
Sterling Capital Management increased its Medtronic (MDT) stake by 903% in Q2 2026, buying an estimated $1.82M and bringing the position to 25,030 shares worth $1.96M. The position accounts for 0.03% of the portfolio, ranked #368.
Sterling Capital Management first reported a position in MDT in Q4 2013 and has held it in 31 quarters since. The position peaked at $114M in Q3 2019. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Sterling Capital Management held 25,030 shares of Medtronic worth $1.96M as of Q2 2026.
- Sterling Capital Management bought 22,535 Medtronic shares in Q2 2026, an estimated $1.82M.
- Medtronic made up 0.03% of Sterling Capital Management's portfolio in Q2 2026, its #368 holding.
- Sterling Capital Management first reported a position in Medtronic in Q4 2013 and has held it in 31 quarters since.
- Sterling Capital Management's Medtronic position peaked at $114M in Q3 2019.
- 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.